Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of SMR001 eye drops in moderate to severe dry eye disease
CTR20254690Phase 3Active
- Sponsor
- Sinobioway Bio-medicine
- Start
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of SMR001 in dry eye syndrome (DED), sponsored by Sinobioway Bio-medicine. Started Dec 2025; status: active.
02
Drugs
SMR001
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20254690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254690.